Objective:To analyze the clinical difference, potential risk factors and pertinent clinical management of neurosurgical site infection (NSSI) between HIV-positive and HIV-negative patients.
Methods:A retrospective analysis was performed on 34 HIV-positive patients and 43 HIV-negative patients who underwent neurosurgical treatments in our department from May 2019 to January 2022. The status of NSSI in the HIV-positive group and the HIV-negative group was compared.Results: There's a statistical difference in the incidence of NSSI between the HIV-positive group and the HIV-negative group. The HIV-positive group was prone to infection and poor healing at the neurosurgical sites, and the incidence of NSSI was related to low body mass index (BMI), hypoalbuminemia, and non-standard antibiotic use in the HIV-positive group. Furthermore, it is statistically different in CD4+T cell count, serum albumin level and antibiotic use for the HIV-positive patients with and without SSI: Patients with low CD4+T count, hypoalbuminemia, and non-standard antibiotic use were prone to SSI.
Conclusions:To reduce NSSI, perioperative CD4+T, serum albumin level and BMI of HIV-positive patients should be increased as much as possible to enhance the immune status of patients, and the rational use of perioperative antibiotics should be strengthened.